← Eichor
Study identifier: NCT07122908 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies

Condition: Dementia With Lewy Bodies  ·  Sponsor: Korea University Anam Hospital

PhasePhase 1/Phase 2
Planned participants10
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

This study aimed to investigate the feasibility of repetitive transcranial magnetic stimulation (rTMS) on the occipital lobe in patients with Lewy body dementia. This is a proof-of-concept study to evaluate the safety and effect of occipital lobe stimulation in patients with Lewy body dementia. Over a period of two weeks, participants will receive rTMS to the primary visual cortex three times a week during visits. For the remaining 10 weeks, maintenance therapy will be administered with rTMS once a week during visits. Efficacy assessments will be conducted on the day of the final stimulation session and again four weeks later.

This description comes directly from the study's public registry record.

Talk to the study team

Kyoungwon Baik, MD, PhD  ·  +8229205510  ·  baikkw88@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Korea University Anam HospitalSeoul, Seoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07122908